DERCUT gouttes buvables fl 50 ml

7680550870020 CH-55087 20.01.2.
DERCUT gouttes buvables fl 50 ml
DERCUT gouttes buvables fl 50 ml
DERCUT gouttes buvables fl 50 ml
1 / 3
google

Details

Product number
5508701
CPT
-
Packaging group
50
Unit
ml
Composition
centella asiatica D6 105 mg, cistus canadensis ex planta tota D4 125 mg, daphne mezereum spag. Peka D4 165 mg, fumaria officinalis spag. Peka D4 125 mg, ledum palustre (HAB) D12 85 mg, ranunculus bulbosus (HAB) D4 165 mg, smilax (HAB) D4 145 mg, viola tricolor spag. Peka D8 85 mg ad solutionem pro 1 g, corresp. ethanolum 21 % V/V.

Articles (1)

Dercut, Tropfen zum Einnehmen
Tropfen zum Einnehmen
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/06/2013
Patient information leaflet
Français
08/06/2013
Patient information leaflet
Italien
08/06/2013

Detailed composition

Substance Quantity Type Category
(N/A)
105.0 MG Substance Wirkstoff (Principe actif)
(N/A)
125.0 MG Substance Wirkstoff (Principe actif)
(N/A)
165.0 MG Substance Wirkstoff (Principe actif)
(N/A)
125.0 MG Substance Wirkstoff (Principe actif)
(N/A)
85.0 MG Substance Wirkstoff (Principe actif)
(N/A)
165.0 MG Substance Wirkstoff (Principe actif)
(N/A)
145.0 MG Substance Wirkstoff (Principe actif)
(N/A)
85.0 MG Substance Wirkstoff (Principe actif)

Authorization holder

ebi-pharm ag

3038 Kirchlindach

Authorization information

Swissmedic authorization number
55087
Drug name
Dercut, Tropfen zum Einnehmen
Galenic form
TROF
Authorization status
Z
Dispensation category
D
First authorization
04/12/2001
Authorization expiration date
31/12/9999
IT number
20.01.2.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei ekzematischen Hautausschlägen

Packaging details

Description (FR)
DERCUT gouttes buvables fl 50 ml
Description (DE)
DERCUT Tropfen zum Einnehmen Fl 50 ml
Market launch
04/12/2001
Narcotic (BTM)
No

Other packaging sizes

DERCUT gouttes buvables fl 100 ml
100 ML
View